DHA diet reduces AD pathology in young APPswe/PS1ΔE9 transgenic mice: Possible Gender Effects

Epidemiological and clinical trial findings suggest that consumption of docosahexaenoic acid (DHA) lowers the risk of Alzhemier’s disease (AD). We examined the effects of short-term (3 months) DHA enriched diet on plaque deposition and synaptic deficts in forebrain of young APPswe/PS1ΔE9 transgenic...

Full description

Saved in:
Bibliographic Details
Main Authors: Perez, Sylvia E., Berg, Brian M., Moore, Kenneth A., He, Bin, Counts, Scott E., Fritz, Jason J., Hu, Yuan-Shih, Lazarov, Orly, Lah, James J., Mufson, Elliott J.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3118087/
https://ncbi.nlm.nih.gov/pubmed/19859965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jnr.22266
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items